Oxaliplatin (Lipoxal, NSC 266046, RP 54780, CAS Number: 61825-94-3) | Cayman Chemical
Platinum Complex - an overview | ScienceDirect Topics
Albumin-targeting of an oxaliplatin-releasing platinum(iv) prodrug results in pronounced anticancer activity due to endocytotic drug uptake in vivo - Chemical Science (RSC Publishing)
Eloxatine | C8H16N2O4Pt | CID 5310940 - PubChem
Platinum Based Cancer Drugs Market Size - Global Industry Report, 2019-2026
The side effects of platinum-based chemotherapy drugs: a review for chemists - Dalton Transactions (RSC Publishing) DOI:10.1039/C8DT00838H
IJMS | Free Full-Text | Nanoparticles Loaded with Platinum Drugs for Colorectal Cancer Therapy
Oxaliplatin, Platinum anticancer agent (CAS 61825-94-3) (ab141054) | Abcam
Oxaliplatin derived monofunctional triazole-containing platinum(II) complex counteracts oxaliplatin-induced drug resistance in colorectal cancer - ScienceDirect
Kinetic Study on the Reactions of Platinum Drugs with Glutathione | Journal of Pharmacology and Experimental Therapeutics
Frontiers | The Drug-Resistance Mechanisms of Five Platinum-Based Antitumor Agents
Structure formulas of platinum-complexes. Cisplatin, Carboplatin, and... | Download Scientific Diagram
A solid-state 17O NMR study of platinum-carboxylate complexes: carboplatin and oxaliplatin
A solid-state 17O NMR study of platinum-carboxylate complexes: carboplatin and oxaliplatin
Oxaliplatin in the era of personalized medicine: from mechanistic studies to clinical efficacy | SpringerLink
IJMS | Free Full-Text | Comparative Study of the Mode of Action of Clinically Approved Platinum-Based Chemotherapeutics
Novel aspects of the preclinical pharmacology of platinum compounds
IJMS | Free Full-Text | Comparative Study of the Mode of Action of Clinically Approved Platinum-Based Chemotherapeutics
Structures of the platinum(II) complexes cisplatin, carboplatin and... | Download Scientific Diagram
Oxaliplatin - Wikipedia
Oxaliplatin: pre-clinical perspectives on the mechanisms of action, response and resistance - ecancer
Johnson Matthey on Twitter: "It's 40 years since the first platinum anti-cancer drug #cisplatin was approved by the US FDA. @compoundchem takes a look at the impact this drug has had on
Platinum-based drugs for cancer therapy and anti-tumor strategies
Platinum-containing-cancer-drugs-different
Synthesis, Structure, and Cytotoxicity of Oxaliplatin-Based Platinum(IV) Anticancer Prodrugs Bearing One Axial Fluoride | Inorganic Chemistry
Chemical structure of cisplatin, carboplatin and oxaliplatin, as drugs... | Download Scientific Diagram
Carboplatin and oxaliplatin in sequenced combination with bortezomib in ovarian tumour models | Journal of Ovarian Research | Full Text
